Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02292485
Other study ID # PA14-0824
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 20, 2014
Est. completion date October 2020

Study information

Verified date January 2020
Source M.D. Anderson Cancer Center
Contact Robert Volk, PHD
Phone 713-563-0020
Email BVolk@mdanderson.org
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Investigators will administer a brief, anonymous survey at the Texas Academy of Family Physicians (TAFP) annual Primary Care Summit to better understand the readiness of primary care physicians in Texas to implement lung cancer screening programs in their practice settings.


Description:

For this project there will be up to 1000 participants. Physicians attending the annual CME event at the Texas Academy of Family Physicians event will be asked to fill out an anonymous survey to better understand their readiness to implement lung cancer screening programs in their practice settings. The surveys will be administered to physicians attending the TAFP education events in Houston, Texas, October 17-19, 2014 and in Dallas, Texas, November 7-9, 2014.


Recruitment information / eligibility

Status Recruiting
Enrollment 1000
Est. completion date October 2020
Est. primary completion date October 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria:

1. Physicians attending the TAFP education events in Houston, Texas, October 17-19, 2014 and in Dallas, Texas, November 7-9, 2014.

Exclusion Criteria:

N/A

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Survey
Physicians complete survey to better understand their readiness to implement lung cancer screening programs in their practice settings. Surveys administered to physicians attending the TAFP education events in Houston, Texas, October 17-19, 2014 and in Dallas, Texas, November 7-9, 2014.

Locations

Country Name City State
United States University of Texas MD Anderson Cancer Center Houston Texas

Sponsors (2)

Lead Sponsor Collaborator
M.D. Anderson Cancer Center Patient-Centered Outcomes Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Lung Cancer Screening Program Readiness Descriptive statistics (eg, rates) used to describe the readiness of primary care physicians to support lung cancer screening programs in their practices. 1 day
See also
  Status Clinical Trial Phase
Completed NCT02944903 - Audit of Lung Cancer Screening Practice in Chest Physicians: An Update N/A
Active, not recruiting NCT05630950 - LDCT-SC-FI Low-dose CT Screening for Lung Cancer N/A
Completed NCT03200236 - The Lung Screening, Tobacco and Health Project Phase 3
Recruiting NCT03853967 - Lung Cancer Screening by Low Dose CT Scan in a French Department (DEP KP80) N/A
Recruiting NCT05645731 - Lung Cancer Screening in Family Members and Peers of Lung Cancer Patients: a Prospective Cohort Study
Completed NCT05920850 - The SHARED, Project, Lung Cancer Screening for African American Men (AAM) N/A
Active, not recruiting NCT03069924 - Gain-framed Messages and NRT for Lung Cancer Screening Patients Phase 2
Completed NCT02899754 - Lung Cancer Screening Decisions N/A
Recruiting NCT06451029 - Prevention of Smoking Related Diseases
Completed NCT03793894 - Inpatient Smokers and LDCT Screening Part 2 N/A
Active, not recruiting NCT04691297 - Digitally Enhanced Smoking Cessation for High Risk Smokers N/A
Completed NCT06444373 - Artificial Intelligence in Lung Cancer Screening
Enrolling by invitation NCT05747443 - Multilevel Interventions to Increase Adherence to Lung Cancer Screening N/A
Active, not recruiting NCT02914899 - Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community Early Phase 1
Recruiting NCT05195385 - Lung Cancer Screening With Low-dose CT Scan in Women : Implementation Study N/A
Completed NCT03958253 - Lung Cancer Screening Protocol N/A